23andMe Holding Co. is a pioneer in consumer genetics testing, offering insights into genetic ancestry, health risks, and how DNA affects medication responses. Beyond personal genetics, it operates Lemonaid telehealth for easy access to medical consultations. In the realm of drug development, 23andMe is actively working on novel therapies in areas like oncology and cardiovascular diseases, aiming to transform patient care. Its innovative approach includes developing drugs that leverage genetic insights, such as a monoclonal antibody in clinical trials for cancer treatment.